After more than sixty years we are still unclear whether LSD has a place in clinical psychiatry

Arthur Saniotis

doi:10.4081/ripppo.2020.464

https://doi.org/10.4081/ripppo.2020.464

Arthur Saniotis | arthur.saniotis@hirszfeld.pl Department of Anthropology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland; Biological Anthropology and Comparative Anatomy Research Unit, Adelaide Medical School, University of Adelaide, Australia.

Abstract

Dear Editor, The use of the psychedelic Lysergic Acid Diethylamide (LSD) has again provoked scientific debate over its efficacy and safety. In the 1950s-1960s LSD was used in psychotherapy for treating depression, anxiety related to terminal cancer, addiction, and pain. (...)

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

Bonson, K. (1996). Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology, 14, 425-436. DOI: https://doi.org/10.1016/0893-133X(95)00145-4

Carhart-Harris, R.L., and Goodwin, G.M. (2017). The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 42, 2105–2113; DOI: https://doi.org/10.1038/npp.2017.84

Carhart-Harris, R.L., Bolstridge, M., & Rucker. J., et al. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry, 3(7), 619-27. DOI: https://doi.org/10.1016/S2215-0366(16)30065-7

Fuentes, J.J., Fonseca, F., Elices, M., Farré., M., & Torrens, M. (2020) Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Front. Psychiatry, 10, 943.

Gasser, P., Kirchner, K., and Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology, 29(1), 57–68. DOI: https://doi.org/10.1177/0269881114555249

Mithoefer, M.C., Wagner, T.M., Mithoefer, A.T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439-452. DOI: https://doi.org/10.1177/0269881110378371

Mithoefer, M.C., Mithoefer, A.T., Feduccia. L., et al. (2018). MDMA-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry, 55(6), 486-497. DOI: https://doi.org/10.1016/S2215-0366(18)30135-4

Nutt, D. (2019). Psychedelic drugs—a new era in psychiatry? Dialogues in Clinical Neuroscience, 21(2), 139-147. DOI: https://doi.org/10.31887/DCNS.2019.21.2/dnutt

Tupper, K.W., Wood, E., Yensen, R., & Johnson, M.W. (2015). Psychedelic medicine: a re-emerging therapeutic paradigm. CMAJ, 187(14), 1054-1059. DOI: https://doi.org/10.1503/cmaj.141124

Ungerleider, J.T., & Adrysiak, T. (1981). Therapeutic uses of the drugs of abuse. Annals of the New York Academy of Sciences, 362, 173-180. DOI: https://doi.org/10.1111/j.1749-6632.1981.tb12805.x